We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$323B
AUM Growth
+$11.5B
Cap. Flow
+$13.1B
Cap. Flow %
4.05%
Top 10 Hldgs %
14.39%
Holding
7,731
New
673
Increased
3,224
Reduced
3,031
Closed
497

Sector Composition

Rank Sector Weight
1 Financials 8.41%
2 Healthcare 8.04%
3 Technology 7.66%
4 Energy 6.94%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
7351
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
-42,700
Closed -$1.51M
SGEN
7352
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
-42,700
Closed -$1.51M
CCF
7353
DELISTED
Chase Corporation
CCF
-5,425
Closed -$237K
NEWR
7354
DELISTED
New Relic, Inc.
NEWR
-16,945
Closed -$588K
CEQP
7355
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
-550
Closed -$33K
HCCI
7356
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-18,596
Closed -$218K
PRTK
7357
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-11,679
Closed -$365K
MTEM
7358
CALL
DELISTED
Molecular Templates, Inc.
MTEM
-606
Closed -$406K
MTEM
7359
PUT
DELISTED
Molecular Templates, Inc.
MTEM
-606
Closed -$406K
SPPI
7360
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-59,400
Closed -$361K
BLCM
7361
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-1,456
Closed -$337K
CSII
7362
DELISTED
Cardiovascular Systems, Inc.
CSII
-7,655
Closed -$299K
ALR
7363
DELISTED
AlerisLife Inc
ALR
-3,461
Closed -$154K
TTM
7364
CALL
DELISTED
Tata Motors Limited
TTM
-21,700
Closed -$978K
TTM
7365
PUT
DELISTED
Tata Motors Limited
TTM
-250,000
Closed -$11.3M
CLVS
7366
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
-50,000
Closed -$3.71M
CLVS
7367
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
-50,000
Closed -$3.71M
AGTC
7368
DELISTED
Applied Genetic Technologies Corporation
AGTC
-23,146
Closed -$463K
ZEN
7369
DELISTED
ZENDESK INC
ZEN
-14,206
Closed -$322K
AERI
7370
PUT
DELISTED
Aerie Pharmaceuticals
AERI
-10,000
Closed -$313K
BRG
7371
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
-10,812
Closed -$144K
HNGR
7372
DELISTED
Hanger Inc.
HNGR
-10,944
Closed -$248K
AMPE
7373
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-53
Closed -$120K
EMWP
7374
DELISTED
Eros Media World PLC
EMWP
-644
Closed -$225K
APTS
7375
DELISTED
Preferred Apartment Communities, Inc.
APTS
-31,817
Closed -$344K

Similar funds

Goldman Sachs's Q2 2015 Portfolio in Review

As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.

  • Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
  • Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
  • Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
  • Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
  • Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
  • Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.